JPMorgan Chase & Co. Purchases 36,905 Shares of Select Medical Holdings Co. (NYSE:SEM)

JPMorgan Chase & Co. raised its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 9.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 416,299 shares of the health services provider's stock after purchasing an additional 36,905 shares during the quarter. JPMorgan Chase & Co. owned about 0.32% of Select Medical worth $14,516,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Principal Financial Group Inc. grew its position in Select Medical by 6.7% in the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider's stock worth $82,208,000 after acquiring an additional 147,032 shares during the period. Franklin Resources Inc. grew its holdings in shares of Select Medical by 12.0% during the 3rd quarter. Franklin Resources Inc. now owns 69,448 shares of the health services provider's stock worth $2,354,000 after purchasing an additional 7,441 shares during the period. Tidal Investments LLC acquired a new stake in shares of Select Medical during the 3rd quarter worth about $286,000. Wilmington Savings Fund Society FSB purchased a new stake in Select Medical in the 3rd quarter valued at about $81,000. Finally, Virtu Financial LLC acquired a new position in Select Medical in the third quarter valued at about $210,000. Hedge funds and other institutional investors own 89.48% of the company's stock.

Insiders Place Their Bets

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the sale, the vice president now owns 30,356 shares of the company's stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by company insiders.

Select Medical Trading Down 2.2 %

Shares of SEM stock traded down $0.41 on Friday, reaching $18.32. 683,770 shares of the stock were exchanged, compared to its average volume of 1,040,828. Select Medical Holdings Co. has a 1-year low of $18.02 and a 1-year high of $40.98. The firm has a 50 day moving average of $25.44 and a two-hundred day moving average of $31.65. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.37 billion, a P/E ratio of 8.56, a price-to-earnings-growth ratio of 0.39 and a beta of 1.45.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same period in the prior year, the company posted $0.46 earnings per share. The firm's quarterly revenue was up 5.7% on a year-over-year basis. On average, research analysts anticipate that Select Medical Holdings Co. will post 1.97 EPS for the current year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 2.73%. The ex-dividend date was Wednesday, November 13th. Select Medical's dividend payout ratio (DPR) is presently 23.36%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on SEM. Benchmark downgraded shares of Select Medical from a "buy" rating to a "hold" rating in a research note on Monday, November 25th. UBS Group dropped their price objective on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a report on Friday, January 3rd. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a report on Tuesday. Finally, Royal Bank of Canada raised their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a report on Monday, November 4th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $39.50.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.